PRF Technologies Ltd. (PRFX)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-09-15 Phase2 Readout

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06810726 Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroisc... PHASE2 Recruiting 30

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis